The Neuronet Project (https://www.imi-neuronet.org/) recently launched its Knowledge Base platform that assembles key information about eighteen Innovative Medicines Initiative-funded projects. The new dashboard includes PD-MitoQUANT within the neurodegeneration portfolio with an aim to boost research collaboration through the identification of gaps, multiply impact and enhance visibility. This one-stop-shop allows users to explore the diverse projects and outputs of the entire portfolio. It also includes links to more than 380 publications and 350 publishable deliverable reports.  

Dr Sinead O'Sullivan, DZNE Dr Sinead O'Sullivan of the German Center for Neurodegenerative Diseases (DZNE) is presenting PD-MitoQUANT research at The 15th International Conference on Alzheimer's and Parkinson's Diseases meeting. The title of Dr O'Sullivan's poster abstract is 'Single-cell analysis of alpha-synuclein-induced mitochondrial dysfunction in-vivo'. The conference will be conducted virtually this year from March 9-14, 2021, and will include forum discussions, symposia, oral and poster presentations devoted to the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development [...]

Prof Ronald Melki, CNRS At the two-day 7th International Congress of Multiple System Atrophy, PD-MitoQUANT PI of the Centre National de la Recherche Scientifique (CNRS) in Paris Prof Ronald Melki will remotely present "Pathogenicity of α-synuclein strains: The pasta story" on February 26, 2021. The time of Prof Melki's talk is 12:05-12:30 Paris time. Browse the meeting program here. Registration information can be found here. About MSA: Multiple system atrophy (MSA) is a progressive neurodegenerative disease characterized by autonomic [...]